Entrectinib in children and young adults with solid or primary CNS tumors harboring <i>NTRK</i>, <i>ROS1</i>, or <i>ALK</i> aberrations (STARTRK-NG)Ami V. Desai, Elizabeth Fox, Giles Robinson et al.|Neuro-Oncology|2022Cited by 136
Myxoid glioneuronal tumor, <i>PDGFRA</i> p.K385‐mutant: clinical, radiologic, and histopathologic featuresCalixto‐Hope G. Lucas, David A. Solomon, Elaine Cham et al.|Brain Pathology|2019Cited by 75
Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1Calixto‐Hope G. Lucas, David A. Solomon, Emily A. Sloan et al.|Acta Neuropathologica|2022Cited by 50
HGG-32. PNOC008: A PILOT TRIAL TESTING THE CLINICAL BENEFIT OF USING MOLECULAR PROFILING TO DETERMINE AN INDIVIDUALIZED TREATMENT PLAN IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED HIGH-GRADE GLIOMA (EXCLUDING DIFFUSE INTRINSIC PONTINE GLIOMA)Andrea Franson, Sabine Mueller, Lindsay Kilburn et al.|Neuro-Oncology|2024Cited by 2